Clinical Trial Boom in China Due to unprecedented economic growth and increased healthcare expenditures, experts predict that by 2012 China will be the world’s fourth largest pharmaceutical market. In addition to increased production and distribution by foreign pharmaceuticals, China has become one of the region’s primary locations for outsourcing clinical ...

Latin America Medical Trials Climate By Karen Politis Virk Several countries in Central and Eastern Europe, Asia, and Latin America are among the most prominent new locations for outsourcing clinical trials. In the past, few clinical trials were conducted in Latin America due to a number of factors, including poverty, ...

Language Barriers in Global Trials Effective native language communication is an essential component in the success of international clinical trials, and as the number of trials conducted in newly emerging regions—including countries in Latin America, Central and Eastern  Europe (CEE), and  Asia—continues  to  increase, so does the challenge of overcoming ...

LANDS OF OPPORTUNITY? Global offshoring has become a prominent industry trend due to the high costs of pharmaceutical and biologicals manufacturing in traditional western markets. This trend is most noticeable in developing countries that can offer high-quality manufacturing capabilities at significantly lower costs. At present 20% of the pharma companies ...

Today’s Russian Clinical Trial Environment International Journal of Clinical Practice 2010 By Karen Politis Virk, M.S. Due to the escalating costs of bringing a drug to market, many pharmaceutical and biotech companies are outsourcing clinical research to emerging regions. In particular, Russian clinical trials are booming. Over the past five years ...